Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on June 25, 2025
Hepion Pharmaceuticals Successfully Completes Application to the OTCQB
GlobeNewswire
·
June 25, 2025
MORRISTOWN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B …
Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
GlobeNewswire
·
June 25, 2025
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening solutions, today announced the success of its ongoing …
Synchronoss Achieves EU-U.S. Data Privacy Framework Certification
GlobeNewswire
·
June 25, 2025
BRIDGEWATER, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss”) (NASDAQ: SNCR), a global leader and innovator in personal cloud platforms for telecoms, today announced that it has achieved certification under the EU-U.S. …
SAIC Awarded $928 Million Prototype Engineering and Mission Integration Contract
GlobeNewswire
·
June 25, 2025
RESTON, Va., June 25, 2025 (GLOBE NEWSWIRE) -- America’s leading mission integrator, Science Applications International Corp. (NASDAQ: SAIC), has been awarded the Hyper-Innovative Operational Prototype Engineering (HOPE) 2.0 contract in support of the U.S. …
Cycurion, Inc. Secures Over $8 Million in New Contracts, Strengthening Cybersecurity Leadership
GlobeNewswire
·
June 25, 2025
MCLEAN, Va., June 25, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces the award of several new contracts totaling over $8 million. These agreements, …
HeartCore Partners with Silver Egg Technology to Integrate New Recommendation Engine into its CMS Platform
GlobeNewswire
·
June 25, 2025
NEW YORK and TOKYO, June 25, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and data consulting services company based in Tokyo, has entered into an OEM sales agreement with …
Eyenovia Announces Co-Branded Validator with Kinetiq
GlobeNewswire
·
June 25, 2025
LAGUNA HILLS, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of …
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire
·
June 25, 2025
RUTHERFORD, N.J. and STOCKHOLM, June 25, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced results …
Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech
GlobeNewswire
·
June 25, 2025
Yokneam Illit, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, …
AgEagle Aerial Systems Announces 100th Drone Sale to South Korea as International Footprint Continues to Expand
GlobeNewswire
·
June 25, 2025
New eBee X units enhance capabilities across agriculture, urban planning, and strategic applications WICHITA, Kan., June 25, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging …
BTC Miner Surges Amid Bitcoin Boom: Users Earn Up to $8,500 Daily with Zero Effort
GlobeNewswire
·
June 25, 2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- As Bitcoin holds steady above $105,000 and Ethereum remains strong beyond $2,500, global investors are increasingly turning to passive income solutions in the crypto sector. Riding this wave is BTC Miner, a …
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
GlobeNewswire
·
June 25, 2025
BERKELEY, Calif. and MAINZ, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that its …
Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus
GlobeNewswire
·
June 25, 2025
Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s pipeline under the name EVX-B4 Urgent need for preventive …
Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors
GlobeNewswire
·
June 25, 2025
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of …
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
GlobeNewswire
·
June 25, 2025
Amneal holds exclusive U.S. commercialization rights; BLA filing expected in Q4 2025 Poised to be among the first wave of biosimilars in the $3.9 billion U.S. omalizumab market and an important growth driver for Amneal BRIDGEWATER, N.J., June 25, 2025 ( …
Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B
GlobeNewswire
·
June 25, 2025
– Favorable safety and tolerability profile, as well as pharmacokinetics supporting once-daily oral dosing, continued to be observed in final 400 mg cohort – – Mean plasma HBV DNA reductions of 3.2 logs IU/mL over 28 days of treatment for 400 mg cohort …
Salsify Names Cory McIntyre as Vice President of Global Network, Strengthening Commitment to PXM Innovation
GlobeNewswire
·
June 25, 2025
BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Salsify, the leading product experience management (PXM) platform that empowers brands, retailers, and distributors to win on the digital shelf, is thrilled to announce the appointment of Cory McIntyre as Vice …
Nametag Sets New Paradigm in Enterprise Identity Verification with Bring-Your-Own-Storage for PII
GlobeNewswire
·
June 25, 2025
SEATTLE, June 25, 2025 (GLOBE NEWSWIRE) -- Nametag, the leader in workforce identity verification, today announced the general availability of Enterprise Data Custody. Enterprise Data Custody allows organizations to store all personally identifiable …
Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab
GlobeNewswire
·
June 25, 2025
Combination cohort initiated following successful review of monotherapy cohort Over 100 participants dosed to-date in monotherapy cohort Priority are Head and Neck Squamous Cell Carcinoma (HNSCC) and cervical cancer Data update on schedule for later this …
Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
GlobeNewswire
·
June 25, 2025
BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that three …